Vital KSK HoldingsTSE:3151 70 PE Ratio (TTM) is 10.28 as of Jul. 09, 2026, which is 16% below its 10-year median of 12.18. GuruFocus rates TSE:3151 with a GF Score™ of 70/100 and a GF Value™ of 円1,324.61 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 87 Medical Distribution companies, Vital KSK Holdings ranks better than 72.41% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-07-09), Vital KSK Holdings's share price is
円1565.00.
Vital KSK Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円152.29. Therefore, Vital KSK Holdings's PE Ratio (TTM) for today is 10.28.
Warning Sign:
Vital KSK Holdings Inc stock PE Ratio (=10.28) is close to 1-year high of 10.77.
The historical rank and industry rank for Vital KSK Holdings's PE Ratio (TTM) or its related term are showing as below:
TSE:3151'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 6.09 Med: 12.18 Max: 129.49
Current: 10.28
During the past 13 years, the highest PE Ratio (TTM) of Vital KSK Holdings was 129.49. The lowest was 6.09. And the median was 12.18.
TSE:3151's PE Ratio (TTM) is ranked better than 72.41% of 87
companies
in the Medical Distribution industry
Industry Median: 16.25
vs TSE:3151: 10.28
During the past 13 years, Vital KSK Holdings's highest 3-Year average EPS without NRI Growth Rate was 33.90% per year. The lowest was -14.00% per year. And the median was 4.40% per year.
Vital KSK Holdings's EPS (Basic) for the
three
months ended in Mar. 2026 was 円30.44.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was 円152.29.
Vital KSK Holdings (TSE:3151) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Vital KSK Holdings PE Ratio (TTM) Related Terms
Vital KSK Holdings PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Vital KSK Holdings's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3151 vs MCK, CAH, COR: PE Ratio (TTM) Comparison
For the Medical Distribution subindustry, Vital KSK Holdings's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vital KSK Holdings PE Ratio (TTM) vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Vital KSK Holdings's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Vital KSK Holdings's Share Price of today is 円1565.00.
Vital KSK Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円152.29.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Vital KSK Holdings (TSE:3151) has a PE Ratio (TTM) of 10.28 as of Jul. 09, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Vital KSK Holdings and its competitors. This is 16% below median its historical median of 12.18. Over the past decade, Vital KSK Holdings' PE Ratio (TTM) has ranged from 6.09 to 129.49. According to the industry distribution chart, Vital KSK Holdings ranks #24 out of 87 companies in the Medical Distribution industry, placing it in the top 27.6%.
Is Vital KSK Holdings' PE Ratio (TTM) too high?
Vital KSK Holdings' current PE Ratio (TTM) of 10.28 is 16% below median its 10-year median of 12.18. Over the past 10 years, this metric has ranged from a low of 6.09 to a high of 129.49. The Medical Distribution industry median PE Ratio (TTM) is 16.25. Vital KSK Holdings' value of 10.28 is 36.7% below this industry median. Based on the distribution chart, Vital KSK Holdings ranks #24 out of 87 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Vital KSK Holdings has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' PE Ratio (TTM) compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Vital KSK Holdings ranks #24 out of 87 companies for PE Ratio (TTM). This puts Vital KSK Holdings in the upper half of its industry. The industry median PE Ratio (TTM) is 16.25. Vital KSK Holdings' value of 10.28 is 36.7% below this benchmark. Historically, Vital KSK Holdings' own PE Ratio (TTM) has ranged from 6.09 to 129.49 over the past decade. While the company's 10-year median is 12.18 vs. the industry median of 16.25, Vital KSK Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Distribution company?
The median PE Ratio (TTM) among Medical Distribution companies is 16.25, based on 87 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vital KSK Holdings's current PE Ratio (TTM) of 10.28 is 36.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Vital KSK Holdings and its competitors. For the Medical Distribution industry, the median PE Ratio (TTM) is 16.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vital KSK Holdings's current PE Ratio (TTM) is 10.28, which is 16% below median its own 10-year median of 12.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vital KSK Holdings (TSE:3151) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,324.61, compared to a current price of 円1,565.00 — trading 18.1% above its estimated fair value. The current PE Ratio (TTM) is 10.28, which is 16% below median its 10-year median of 12.18 and 36.7% below the Medical Distribution industry median of 16.25. Vital KSK Holdings' overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Vital KSK Holdings (TSE:3151), the current PE Ratio (TTM) is 10.28 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital KSK Holdings (TSE:3151) Overvalued in 2026?
Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued.
The current stock price of 円1,565.00 is trading 18.1% above its estimated GF Value™ of 円1,324.61.
GuruFocus considers Vital KSK Holdings to be Modestly Overvalued.
Key valuation signals for TSE:3151:
PE Ratio (TTM): 10.28 (16% below median its 10-year median of 12.18)
GF Value™: 円1,324.61 vs. price of 円1,565.00 (18.1% above fair value)
Industry Position: 36.7% below the Medical Distribution median (#24 of 87)
No single metric tells the full story. See the TSE:3151 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
70GF Score
Get the complete analysis for TSE:3151
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3151 has been successfully added to your 
